IP Library › Assignment 069171/0875
Patent Assignment
Reel/Frame 069171/0875

Assignment of Assignor's Interest

Recorded: 2024-10-15 Pages: 29
Assignor
VARIAN BIOPHARMACEUTICALS, INC.
Executed: 2024-04-02
Assignee
WINDTREE THERAPEUTICS, INC.
2600 KELLY ROAD, SUITE 100, WARRINGTON, PENNSYLVANIA, 18976
Covered Properties (18)
Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
Application: 62/825,334 →
Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
Application: 17/598,719 →
Publication: US 2022/0143028
Thienopyrimidine Inhibitors of Atypical Protein Kinase C
Application: 61/563,310 →
Thienopyrimidine Inhibitors of Atypical Protein Kinase C
Patent: 9,604,994 →
Application: 14/285,007 →
Publication: US 2014/0323435
Thienopyrimidine Inhibitors of Atypical Protein Kinase C
Application: 15/417,191 →
Publication: US 2017/0158706
Thienopyrimidine Inhibitors of Atypical Protein Kinase C
Application: 16/212,582 →
Publication: US 2019/0106433
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Application: 61/707,340 →
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Application: 61/781,364 →
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Patent: 9,914,730 →
Application: 14/038,915 →
Publication: US 2014/0113882
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Patent: 9,896,446 →
Application: 14/975,605 →
Publication: US 2016/0102094
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Application: 61/970,006 →
Azaquinazoline Inhibitors Of Atypical Protein Kinase C
Application: 14/668,022 →
Publication: US 2015/0274720
Solid Forms of {5-Cyclopropyl-2-[2-(3,6-Difluoro-Pyridin-2-Ylamino)-Pyridin-4-Yl]-Pyrido[3,4-D]Pyrimidin-4-Yl}-((S)-3,3-Dimethyl-Piperidin-4-Yl)-Amine
Application: 63/387,200 →
Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
Thienopyrimidine Inhibitors of Atypical Protein Kinase C
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Solid Forms of {5-Cyclopropyl-2-[2-(3,6-Difluoro-Pyridin-2-Ylamino)-Pyridin-4-Yl]-Pyrido[3,4-D]Pyrimidin-4-Yl}-((S)-3,3-Dimethyl-Piperidin-4-Yl)-Amine
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 14, 2012
From: DORSEY, BRUCE D.; LEARN, KEITH S.; MORRIS, EMMA L.; OTT, GREGORY R.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 027700/0874 →
Assignment of Assignor's Interest Jan 29, 2013
From: BRESLIN, HENRY J.; DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; FOWLER, KATHERINE M.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 029712/0530 →
Assignment of Assignor's Interest Jan 10, 2014
From: BRESLIN, HENRY J.; DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; FOWLER, KATHERINE M.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 031939/0332 →
Assignment of Assignor's Interest Apr 24, 2014
From: DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; FOWLER, KATHERINE M.; HUDKINS, ROBERT L.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 032744/0651 →
Assignment of Assignor's Interest Jul 21, 2014
From: DORSEY, BRUCE D.; LEARN, KEITH S.; MORRIS, EMMA L.; OTT, GREGORY R.
To: CANCER RESEARCH TECHNOLOGY LIMITED; CEPHALON, INC.
Reel/Frame 033349/0530 →
Assignment of Assignor's Interest Mar 17, 2015
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 035186/0151 →
Assignment of Assignor's Interest Mar 17, 2015
From: BRESLIN, HENRY J.; DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; HUDKINS, ROBERT L.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 035186/0056 →
Assignment of Assignor's Interest Jan 13, 2016
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 037476/0732 →
Assignment of Assignor's Interest Jan 13, 2016
From: DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; FOWLER, KATHERINE M.; HUDKINS, ROBERT L.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 037509/0272 →
Assignment of Assignor's Interest Jan 20, 2016
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 037529/0079 →
Assignment of Assignor's Interest Jan 20, 2016
From: BRESLIN, HENRY J.; DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; HUDKINS, ROBERT L.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 037529/0187 →
Assignment of Assignor's Interest Jun 2, 2016
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 038791/0729 →
Assignment of Assignor's Interest Jan 13, 2017
From: IGNYTA, INC.
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 040964/0825 →
Assignment of Assignor's Interest Jan 18, 2019
From: DORSEY, BRUCE D.; OTT, GREGORY R.; LEARN, KEITH S.; MORRIS, EMMA L.
To: CANCER RESEARCH TECHNOLOGY LIMITED; CEPHALON, INC.
Reel/Frame 048063/0558 →
Assignment of Assignor's Interest Jan 18, 2019
From: IGNYTA, INC.
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 048063/0607 →
Assignment of Assignor's Interest Jan 18, 2019
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 048063/0580 →
Assignment of Assignor's Interest Nov 5, 2020
From: ORO, ANTHONY E.
To: CANCER RESEARCH TECHNOLOGY LTD
Reel/Frame 054287/0450 →
Assignment of Assignor's Interest Dec 31, 2021
From: ORO, ANTHONY E.
To: CANCER RESEARCH TECHNOLOGY LTD
Reel/Frame 058513/0618 →
Assignment of Assignor's Interest Dec 12, 2023
From: AMEDIO, JOHN C.
To: VARIAN BIOPHARMACEUTICALS, INC.
Reel/Frame 065847/0155 →